Deakin University
Browse

File(s) under permanent embargo

Current markers of the Athlete Blood Passport do not flag microdose EPO doping

journal contribution
posted on 2011-09-01, 00:00 authored by M Ashenden, C E Gough, Andrew GarnhamAndrew Garnham, C J Gore, K Sharpe
The Athlete Blood Passport is the most recent tool adopted by anti-doping authorities to detect athletes using performance-enhancing drugs such as recombinant human erythropoietin (rhEPO). This strategy relies on detecting abnormal variations in haematological variables caused by doping, against a background of biological and analytical variability. Ten subjects were given twice weekly intravenous injections of rhEPO for up to 12 weeks. Full blood counts were measured using a Sysmex XE-2100 automated haematology analyser, and total haemoglobin mass via a carbon monoxide rebreathing test. The sensitivity of the passport to flag abnormal deviations in blood values was evaluated using dedicated Athlete Blood Passport software. Our treatment regimen elicited a 10% increase in total haemoglobin mass equivalent to approximately two bags of reinfused blood. The passport software did not flag any subjects as being suspicious of doping whilst they were receiving rhEPO. We conclude that it is possible for athletes to use rhEPO without eliciting abnormal changes in the blood variables currently monitored by the Athlete Blood Passport.

History

Journal

European journal of applied physiology

Volume

111

Issue

9

Pagination

2307 - 2314

Publisher

Springer-Verlag

Location

Heidelberg, Germany

ISSN

1439-6319

eISSN

1439-6327

Language

eng

Publication classification

C Journal article; C1.1 Refereed article in a scholarly journal

Copyright notice

2011, Springer-Verlag